| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-15 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-13 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-12 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-11 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
5e-11 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-11 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-10 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |